| donepezil / Generic mfg. |
NCT00035204: A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease |
|
|
| Completed | 4 | 63 | US | galantamine | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Ortho-McNeil Neurologics, Inc. | Alzheimer Disease | | 05/03 | | |
NCT00293176: The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI) |
|
|
| Completed | 4 | 821 | US | Donepezil Hydrochloride, Placebo | Eisai Inc., Pfizer | Memory Loss | 03/07 | 03/07 | | |
NCT00230568: EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) |
|
|
| Completed | 4 | 100 | US | Aricept | Eisai Inc., Pfizer | Alzheimer's Disease | 04/07 | 12/07 | | |
NCT00934375: A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment |
|
|
| Completed | 4 | 145 | US | Aricept (donepezil hydrochloride), donepezil hydrochloride, placebo | Eisai Inc. | Mild Cognitive Impairment | 09/07 | 09/07 | | |
NCT00369603: Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients |
|
|
| Terminated | 4 | 4 | US | Razadyne ER, Aricept | Duke University, Ortho-McNeil Neurologics, Inc. | Alzheimer's Disease | 10/07 | 11/07 | | |
NCT00403520: Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers |
|
|
| Completed | 4 | 240 | Europe | Experimental 1, Placebo Comparator | Eisai Inc. | Alzheimer's Disease | 03/08 | 08/10 | | |
NCT00165750: Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients |
|
|
| Terminated | 4 | 40 | RoW | DONEPEZIL HYDROCHLORIDE, Aricept | Eisai Korea Inc. | Alzheimer's Disease | 08/08 | 11/08 | | |
NCT00571064: The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility |
|
|
| Completed | 4 | 97 | US | Donepezil HCl, Aricept | Eisai Inc., Pfizer | Mild to Severe Alzheimer's Disease | 12/08 | 04/09 | | |
NCT00711204: Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease |
|
|
| Withdrawn | 4 | 0 | US | Donepezil Hydrochloride (Aricept), Aricept | Eisai Inc., Pfizer | Severe Alzheimer's Disease | 06/09 | | | |
NCT00165763: Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia |
|
|
| Completed | 4 | 36 | RoW | donepezil hydrochloride (Aricept), Aricept | Eisai Inc., Eisai Co., Ltd. | Vascular Dementia | 09/09 | | | |
NCT01478633: Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil |
|
|
| Completed | 4 | 102 | Japan | Galantamine | Janssen Pharmaceutical K.K. | Alzheimer's Disease | 06/13 | 06/13 | | |
NCT02097056: Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease |
|
|
| Completed | 4 | 171 | RoW | Donepezil HCL | Eisai Korea Inc. | Alzheimer's Disease | 05/15 | 05/15 | | |
| Withdrawn | 4 | 0 | Europe | Cerebrolysin, Cognicer, Renacenz, Donepezil, Other names:, e.g. Aricept, Donesyn | Ever Neuro Pharma GmbH | Alzheimer Disease | 09/16 | 12/16 | | |
NCT02345213: A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB) |
|
|
| Completed | 4 | 160 | Japan | E2020, Placebo | Eisai Co., Ltd. | Dementia, Lewy Body, Lewy Body Disease | 05/17 | 03/18 | | |
